🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📅Mark your calendars for ECHO PITCH 2023 TBEP_UofT ➡3 of the 6 companies finalists are UTEST companies! Blue Ocean Technologies, FocalViz, HDAX Therapeutics, and others will deliver compelling pitches, competing for funding from a pool of $250,000. tedrogersresearch.ca/echo-pitch/

Big milestone for Zucara as we dosed our first patient in the Phase 2a ZONE study! The ZONE study will evaluate the effect of ZT-01 on preventing nighttime hypoglycemia (low blood glucose) in people with Type 1 diabetes. zucara.ca/news/zucara-th…

Congratulations to our portfolio company Zucara Therapeutics on reaching the important milestone of dosing first patient. This is truly good news for Zucara as well as diabetes patients. lnkd.in/gN48gNr5 #TIAPportfolio #diabetes

TIAP is very pleased to partner with OBIO and others in this new initiative and to help make the LSCTC Centre of Excellence a success. Thank you to the Ontario Government for its support to get this off the ground.

It has been almost a year since Amgen 🧪🔬🧬 joined our LAB150 partnership w/Evotec. TIAP visited Evotec's facility in Toulouse earlier this week for talks around collaboration & strategy. Thank you to our friends from Evotec & Amgen for hosting a great visit!

Our colleagues, Phil Goldbach & Justin Grant had a great time playing road hockey for the 1st time to support Conquer Cancer. Brad Wouters 🇨🇦, EVP at Commercialization at University Health Network, didn't play this time but we hear strategy points were discussed (yelled?) at intervals! #TIAPatplay

We are hiring! We are looking for an Analyst/Sr. Analyst for our Life Sciences team. We would love to hear from you if you are passionate about science and keen to help commercialize research from our Members. lnkd.in/g8SYd7Nh #TIAPjobs

We are thrilled that Barry Gee has joined TIAP as our new Director, Public Affairs. Barry has extensive experience helping build Canada’s life science ecosystem. We are thrilled to benefit from his expertise to promote & support our commercialization efforts. Welcome, Barry!

Calling all U of T startups! Applications are now open for the 2024 Desjardins Startup Prize. What are you waiting for? Apply now for your chance to win prize money and take your startup to the next level! uoft.me/2024-startup-p…

TIAP continues to strengthen its team’s expertise & are happy to introduce you to two new colleagues in our Venture Builder program: Justin Grant, Director, and Mobeen Lalani, Analyst. We encourage you to read more about Justin and Mobeen:tiap.ca/team/ #TIAPteam

This is always an interesting and informative event. TIAP has been a sponsor in the past and will be again for 2024. Register to see what's new, what's promising!

thank you Life Sciences Ontario for highlighting our strategic partnership w/Amgen 🧪🔬🧬 & Evotec. That's what it's all about - collaborating to drive successful life science startups that will benefit us all! #lifescience FedDev Ontario

Have you applied to #OBIO’s Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence? #LSCTC will help small & medium-sized Ontario companies in the #lifesciences sector to adopt, develop & bring to market #criticaltechnologies. tinyurl.com/2rzybz84

Thank you,Intellectual Property Ontario - nice recognition of one of TIAP's and UTEST, University of Toronto's valued and long-time employees who continues to make a positive impact on the LS innovation sector.

We are pleased to announce that the Independent Data and Safety Monitoring Board recommended the continuation of the Phase 2a trial (NCT05123755) evaluating the efficacy, safety, and tolerability of AV-001 in patients suffering with Acute Respiratory... businesswire.com/news/home/2023…

TIAP is committed to helping build globally-competitive cos. here in Ontario with the potential to improve the health of people worldwide with novel innovations. We are proud that Vasomune Therapeutics, Inc. is one of those companies, and we congratulate them on today’s announcement - well done!

TIAP will be there. We hope you will too!

Congrats to our portfolio company AmacaThera on closing its latest financing. Proud to have been able to offer support for their early pre-clinical dev, IP filings & also seed investment thru our uTest & Venture Builder programs. Another step forward for Ontario #lifesciences!

After 15 great yrs at MaRS it’s time for us to move to a new home. We are happy to announce that we’ll now be supporting Ontario’s amazing innovators and entrepreneurs from our new offices at the Schwartz Reisman Innovation Campus (SRIC) just on the other side of the street!